Harmonic Discovery

Novel kinase inhibitor therapeutics

Harmonic Discovery develops multi-target kinase inhibitors for patients with cancer and autoimmune diseases using a machine learning drug discovery platform.

Reverie Labs

The company develops machine learning software to design small-molecule kinase inhibitors for pharmaceutical firms and research institutions.

AI-enabled drug design

This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.

Meliora Therapeutics

This company develops a machine-learning platform to identify drug mechanisms and create precision oncology treatments for pharmaceutical partners and cancer patients.

Earendil Labs

The company develops an artificial intelligence platform to discover and design biologic medicines for pharmaceutical companies and patients with autoimmune diseases and cancer.

Drug Discovery

This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.

Auron Therapeutics

This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.

Valence Discovery

This company provides a machine learning platform for molecular design and lead optimisation to pharmaceutical and biotechnology firms.